TMCI — Treace Medical Concepts Share News
0.000.00%
Last trade - 00:00- $262.09m
- $275.68m
- $212.69m
Brief: Treace Medical Concepts Inc. Announces Proposed Public Offering Of Common Stock
Brief: Treace Medical Concepts Inc Files For Mixed Shelf, Size Not Disclosed - SEC Filing
Brief: Treace Medical Concepts Says Prelim Unaudited Revenue For FY 2022 Anticipated To Be In Range Of $141.2 Mln To $141.7 Mln
Brief: Treace Medical Concepts Announces Expansion Of Its Global IP Portfolio With The Grant Of Two New U.S. Patents
Brief: Treace Receives FDA 510(K) Clearance For Speedplate™ Rapid Compression Implant Technology
Brief: Treace Announces First Patient Treated In Mta3d Adductoplasty Clinical Study
Brief: Treace Medical Concepts Reports Third Quarter 2022 Financial Results
Treace Medical Concepts Inc reports results for the quarter ended in September - Earnings Summary
Treace Medical Concepts Inc expected to post a loss of 29 cents a share - Earnings Preview
Brief: Treace Announces Updated ALIGN3D Data At 2022 AOFAS Annual Meeting
Treace Medical Concepts Inc reports results for the quarter ended in June - Earnings Summary
Brief: Treace Medical Concepts Reports First Quarter 2022 Financial Results
Treace Medical Concepts Inc reports results for the quarter ended in March - Earnings Summary
Brief: Treace Announces Peer-Reviewed Publication Of Align3d™ Multicenter Prospective Clinical Data
Treace Medical Concepts Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Treace Secures Up To $150 Million In Debt Financing
Brief: Treace Files Patent Infringement Suit To Protect Lapiplasty Bunion Technology
Treace Medical Concepts Inc reports results for the quarter ended in December - Earnings Summary
Brief: Treace Medical Concepts Reports Q4 Loss Per Share Of $0.12